![Mike Westby](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mike Westby
Director Ejecutivo en Agalimmune Ltd. .
Cargos activos de Mike Westby
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Agalimmune Ltd.
![]() Agalimmune Ltd. Pharmaceuticals: MajorHealth Technology Part of BioLineRx Ltd., Agalimmune Ltd. is a British company that develops anti-cancer immunotherapy technology. The company is based in London, UK. The company was founded by Charles Campbell Roberts and Graham Griffiths. The CEO is Mike Westby. Agalimmune was acquired by BioLineRx Ltd. on March 23, 2017 for $6.05 million. | Director Ejecutivo | - | - |
Avvinity Therapeutics Ltd.
![]() Avvinity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Avvinity Therapeutics Ltd. develops novel immuno-therapeutics. The British company was founded in 2016 by Mike Westby, Jonathan David Moore. The CEO is Nick Staples. | Director/Miembro de la Junta | 01/01/2016 | - |
Fundador | 01/01/2016 | - |
Historial de carrera de Mike Westby
Antiguos cargos conocidos de Mike Westby.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Centauri Therapeutics Ltd.
![]() Centauri Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Centauri Therapeutics Ltd. engages in manufacturing processing drugs in pharmaceutical preparations for life threatening diseases. The firm focuses on on the discovery and development of novel molecules targeting life threatening diseases. The company was founded by Mike Westby and Stuart Lawson and is headquartered in Sandwich, the United Kingdom. | Director/Miembro de la Junta | 01/09/2015 | - |
Director Ejecutivo | 01/09/2015 | - | |
Fundador | 01/09/2015 | - | |
Loxbridge Research LLP
![]() Loxbridge Research LLP Financial ConglomeratesFinance Loxbridge Research LLP operates as an investment and project management company. It specializes in startup, early stage, and later stage investments in growth stage companies. The firm supports scientists and focuses on sectors like science, medicine and healthcare technology particularly biotech, med-tech, noval therapeutic, diagnostics, cancer, infectious diseases, neurodegeneration, imaging hardware and software, and enabling devices. The company was founded by Charles Roberts in 2008 and is headquartered in London, the United Kingdom. | Director/Miembro de la Junta | - | - |
Corporate Officer/Principal | - | - |
Formación de Mike Westby.
University of Warwick | Doctorate Degree |
Estadísticas
Internacional
Reino Unido | 6 |
Operativa
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Founder | 2 |
Sectorial
Health Technology | 4 |
Finance | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Loxbridge Research LLP
![]() Loxbridge Research LLP Financial ConglomeratesFinance Loxbridge Research LLP operates as an investment and project management company. It specializes in startup, early stage, and later stage investments in growth stage companies. The firm supports scientists and focuses on sectors like science, medicine and healthcare technology particularly biotech, med-tech, noval therapeutic, diagnostics, cancer, infectious diseases, neurodegeneration, imaging hardware and software, and enabling devices. The company was founded by Charles Roberts in 2008 and is headquartered in London, the United Kingdom. | Finance |
Agalimmune Ltd.
![]() Agalimmune Ltd. Pharmaceuticals: MajorHealth Technology Part of BioLineRx Ltd., Agalimmune Ltd. is a British company that develops anti-cancer immunotherapy technology. The company is based in London, UK. The company was founded by Charles Campbell Roberts and Graham Griffiths. The CEO is Mike Westby. Agalimmune was acquired by BioLineRx Ltd. on March 23, 2017 for $6.05 million. | Health Technology |
Centauri Therapeutics Ltd.
![]() Centauri Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Centauri Therapeutics Ltd. engages in manufacturing processing drugs in pharmaceutical preparations for life threatening diseases. The firm focuses on on the discovery and development of novel molecules targeting life threatening diseases. The company was founded by Mike Westby and Stuart Lawson and is headquartered in Sandwich, the United Kingdom. | Health Technology |
Avvinity Therapeutics Ltd.
![]() Avvinity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Avvinity Therapeutics Ltd. develops novel immuno-therapeutics. The British company was founded in 2016 by Mike Westby, Jonathan David Moore. The CEO is Nick Staples. | Health Technology |
- Bolsa de valores
- Insiders
- Mike Westby
- Experiencia